tiprankstipranks
Park Dental Partners, Inc. (PARK)
NASDAQ:PARK
US Market
Want to see PARK full AI Analyst Report?

Park Dental Partners, Inc. (PARK) AI Stock Analysis

11 Followers

Top Page

PARK

Park Dental Partners, Inc.

(NASDAQ:PARK)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
$23.50
▲(28.28% Upside)
Action:Reiterated
Date:08/11/26
The score is primarily held back by financial fundamentals—ongoing weak profitability and historically high balance-sheet risk—despite consistently positive cash generation. Technical indicators are supportive (price above key moving averages with positive momentum), but valuation is a major headwind due to the extremely high P/E. Recent communications and events add a modest positive tilt via maintained guidance and growth/M&A expansion, tempered by near-term GAAP cost pressure and integration/timing risks.
Positive Factors
Sustained Revenue Growth
Mid-single-digit revenue growth across both existing practices and service lines indicates continued patient demand and provider expansion. Same-practice growth also suggests the business is not relying solely on acquisitions to expand its revenue base.
Negative Factors
Persistent GAAP Losses
Despite positive adjusted EBITDA, reported profitability remains vulnerable to share-based compensation, public-company expenses, and acquisition costs. Continued GAAP losses could limit internally funded growth and make earnings quality less dependable over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Mid-single-digit revenue growth across both existing practices and service lines indicates continued patient demand and provider expansion. Same-practice growth also suggests the business is not relying solely on acquisitions to expand its revenue base.
Read all positive factors

Park Dental Partners, Inc. (PARK) vs. SPDR S&P 500 ETF (SPY)

Park Dental Partners, Inc. Business Overview & Revenue Model

Company Description
Park Dental Partners, Inc. operates as a dental support organization, providing a wide array of non-clinical and operational assistance to dental professionals throughout Minnesota and Wisconsin. The company furnishes its network of affiliated gen...
How the Company Makes Money
null...

Park Dental Partners, Inc. Earnings Call Summary

Earnings Call Date:May 13, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Mar 03, 2027
Earnings Call Sentiment Positive
The call conveyed solid operational momentum with mid-single-digit revenue growth (6.2% YoY), healthy same-practice growth (4.1%), positive adjusted EBITDA and cash flow, a strong patient retention rate (>90%), and a robust M&A pipeline and balance sheet. Near-term GAAP profitability is pressured by elevated share-based compensation (IPO vesting acceleration), higher public company costs, and a larger share count that depresses GAAP EPS versus prior year. Management maintained full-year guidance and emphasized continued investments in capacity and disciplined M&A. Overall, positive operational and liquidity indicators outweigh the near-term GAAP expense headwinds and seasonality risks.
Positive Updates
Revenue Growth
Q1 revenue of $62.7M, representing 6.2% year-over-year growth, driven by organic patient demand and provider base expansion.
Negative Updates
GAAP Net Loss and EPS Decline
GAAP net loss of $0.4M (loss of $0.09 per share) in Q1 2026 versus net income of $1.6M ($0.88 per share) in Q1 2025, reflecting higher GAAP expenses post-IPO and share recognition timing.
Read all updates
Q1-2026 Updates
Negative
Revenue Growth
Q1 revenue of $62.7M, representing 6.2% year-over-year growth, driven by organic patient demand and provider base expansion.
Read all positive updates
Company Guidance
Park Dental maintained its full‑year 2026 outlook after a Q1 that produced $62.7M of revenue (up 6.2% YoY) with same‑practice revenue growth of 4.1%, general practice revenue of $46.1M (+6.4%) and multi‑specialty revenue of $16.6M (+5.7%); adjusted EBITDA was $4.7M (7.6% margin) and adjusted EPS $0.44, while GAAP showed a net loss of $0.4M (‑$0.09/sh) versus prior‑year Q1 net income of $1.6M ($0.88/sh). The company ended the quarter with $24.4M of cash, $11.5M of total debt, an undrawn $15M revolver, and $5M of operating cash flow; it has 221 doctors across three states and patient retention just over 90%. Management said elevated share‑based compensation (about 91% attributable to doctor shareholders) and public‑company costs are expected post‑IPO but will decline as accelerated vesting is recognized, reiterated that M&A is the primary growth lever (with de novos a smaller driver), plans to enter 2–3 new markets over the next few years, and expects Q2 revenue growth to be lower than Q1 with Q3–Q4 tracking at or above Q1 as seasonal hiring and year‑end/early‑year acquisitions are integrated into the second half.

Park Dental Partners, Inc. Financial Statement Overview

Summary
Cash flow is consistently positive with improving free cash flow (a key strength), but overall fundamentals are weighed down by weak profitability (negative net income and operating profit) and a historically high-risk balance sheet with negative equity and elevated leverage, reducing confidence despite signs of improvement in the latest period.
Income Statement
34
Negative
Balance Sheet
22
Negative
Cash Flow
63
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023
Income Statement
Total Revenue251.37M244.49M229.79M223.51M
Gross Profit27.38M32.16M34.13M27.34M
EBITDA74.00K12.34M17.50M10.57M
Net Income-3.54M-358.00K-8.66M-2.28M
Balance Sheet
Total Assets186.27M197.03M154.52M155.12M
Cash, Cash Equivalents and Short-Term Investments24.40B25.18B2.67M558.00K
Total Debt60.10M60.35M62.16M61.05M
Total Liabilities156.45M175.23M158.82M157.41M
Stockholders Equity29.82M21.80M-4.30M-2.29M
Cash Flow
Free Cash Flow4.97B10.29M10.31M3.83M
Operating Cash Flow9.72B17.63M16.47M13.05M
Investing Cash Flow-8.20B-10.65M-7.67M-14.05M
Financing Cash Flow-2.29B15.53M-6.68M465.00K

Park Dental Partners, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$26.13B27.1511.57%0.97%6.41%33.31%
66
Neutral
$4.47B46.754.10%11.89%85.76%
66
Neutral
$4.47B22.4347.30%0.79%14.02%31.92%
56
Neutral
$104.33M-25.57-0.05%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
$207.51M-2.60-33.27%-19.00%40.98%
45
Neutral
$47.01M-0.21-53.15%-32.40%-969.05%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PARK
Park Dental Partners, Inc.
21.20
10.95
106.83%
LH
Labcorp Holdings
330.44
55.25
20.08%
NVST
Envista Holdings
27.58
6.86
33.11%
AMWL
American Well
12.40
5.55
81.02%
DCGO
DocGo
0.42
-1.19
-73.91%
CON
Concentra Group Holdings Parent, Inc.
34.77
11.83
51.55%

Park Dental Partners, Inc. Corporate Events

Business Operations and StrategyM&A Transactions
Park Dental Partners Acquires Village Family Dental DSO
Positive
Aug 10, 2026
On August 7, 2026, Park Dental Partners, Inc. signed a transaction agreement to acquire the dental services organization supporting Village Family Dental, a leading multi-specialty group based in Fayetteville, North Carolina, with completion targe...
Executive/Board ChangesShareholder Meetings
Park Dental Shareholders Approve Director Election and Auditor
Neutral
Jun 2, 2026
On May 29, 2026, Park Dental Partners, Inc. held its 2026 Annual Meeting of Shareholders, at which investors voted on board composition and auditor selection, with 5,279,595 of 6,608,919 eligible shares represented, constituting a quorum. Sharehol...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 11, 2026